We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

140 hedge funds and large institutions have $571M invested in Arena Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 37

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

4% more funds holding

Funds holding: 134 → 140 (+6)

27% less capital invested

Capital invested by funds: $787M → $571M (-$216M)

38% less call options, than puts

Call options by funds: $34.7M | Put options by funds: $56.2M

Holders
140
Holders Change
+6
Holders Change %
+4.48%
% of All Funds
4.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
26
Increased
54
Reduced
37
Closed
19
Calls
$34.7M
Puts
$56.2M
Net Calls
-$21.6M
Net Calls Change
-$9.28M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$17.9M
2
State Street
State Street
Massachusetts
+$11.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.6M
4
BFA
BlackRock Fund Advisors
California
+$7.44M
5
Invesco
Invesco
Georgia
+$5.91M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$20.3M
2
DM
Deerfield Management
New York
-$9.08M
3
Capital Fund Management (CFM)
Capital Fund Management (CFM)
France
-$5.64M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.83M
5
Bank of America
Bank of America
North Carolina
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
VanEck Associates
26
VanEck Associates
New York
$2.72M +$27.5K +409 +0.8%
Charles Schwab
27
Charles Schwab
California
$2.68M +$137K +2,038 +4%
Goldman Sachs
28
Goldman Sachs
New York
$2.61M -$1.53M -22,778 -32%
American Century Companies
29
American Century Companies
Missouri
$2.54M +$2.07M +30,789 +178%
AllianceBernstein
30
AllianceBernstein
Tennessee
$2.44M -$17.2K -256 -0.6%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$2.06M +$81.4K +1,212 +3%
Citadel Advisors
32
Citadel Advisors
Florida
$1.98M -$3.83M -57,073 -60%
HCM
33
Highbridge Capital Management
New York
$1.97M +$2.5M +37,261 New
TA
34
Teachers Advisors
New York
$1.59M +$90.2K +1,343 +5%
Group One Trading
35
Group One Trading
Illinois
$1.57M +$2.01M +29,889 New
Bank of America
36
Bank of America
North Carolina
$1.55M -$2.71M -40,369 -58%
Nomura Holdings
37
Nomura Holdings
Japan
$1.51M +$1.67M +24,826 +636%
GH
38
GAM Holding
Switzerland
$1.45M +$1.85M +27,493 New
Allianz Asset Management
39
Allianz Asset Management
Germany
$1.35M – – –
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$1.25M -$13.4K -199 -0.8%
BL
41
Bolton LP
Connecticut
$1.24M +$1.58M +23,590 New
State Board of Administration of Florida Retirement System
42
State Board of Administration of Florida Retirement System
Florida
$1.24M +$238K +3,546 +18%
ProShare Advisors
43
ProShare Advisors
Maryland
$1.16M +$217K +3,234 +17%
Swiss National Bank
44
Swiss National Bank
Switzerland
$991K -$67.8K -1,010 -5%
MLICM
45
Metropolitan Life Insurance Company (MetLife)
New York
$945K – – –
NFA
46
Nationwide Fund Advisors
Ohio
$913K +$55.5K +826 +5%
SG Americas Securities
47
SG Americas Securities
New York
$835K -$216K -3,221 -17%
JP Morgan Chase
48
JP Morgan Chase
New York
$812K -$501K -7,460 -33%
BA
49
BlackRock Advisors
Delaware
$810K +$155K +2,311 +18%
BG
50
BlackRock Group
United Kingdom
$767K +$46.7K +696 +5%
1
2
3 4 5

ARNA Hedge Fund Activity: Q3 2013 in Review

140 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2013, worth a combined $571M — down 27% from $787M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ARNA positions and 19 closed out — a net gain of 7 holders — while 54 added to existing stakes and 37 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $17.9M. The largest seller was Federated Hermes, exiting entirely with an estimated $20.3M sold.

  • 140 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2013, up from 134 in Q2 2013.
  • Funds reported $571M of Arena Pharmaceuticals Inc stock for Q3 2013, down 27% quarter-over-quarter.
  • 26 funds opened new Arena Pharmaceuticals Inc positions in Q3 2013 and 19 closed out, a net change of +7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2013 was Wellington Management Group, an estimated $17.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2013 was Federated Hermes, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2013.